Abstract
The new class of vasodilators, the calcium antagonists, differs from the previously available drugs, such as hydralazine, guancydine, and minoxidil, in that they do not cause sodium and water retention in acute and short-term usage. This is particularly evident during acute administration when both verapamil and nifedipine induce an increase in urinary sodium and urine volume in spite of the significant blood pressure reduction. The effect of calcium antagonists on sodium and water metabolism is due to a direct tubular action of these drugs and independent from the glomerular filtration rate and renal plasma flow, which are unmodified or only slightly increased. Finally, the natriuretic and diuretic effects of calcium antagonists during intravenous administration are evident at doses lower than those necessary to reduce elevated blood pressure. However, it appears also that by increasing the doses of felodipine, a dihydropyridine derivative, there is a decrease in glomerular filtration rate that can overwhelm the direct tubular action responsible for the diuretic and natriuretic effects.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.